Data shows numerous children in England given GLP-1 weight-loss medications

Freedom of information data obtained from the NHS Business Services Authority shows that hundreds of prescriptions for GLP-1 medications, such as Wegovy and Mounjaro, were issued to children under 18 in England. This includes prescriptions for children under the age of 12, though experts note that private prescriptions, prison settings, and hospital distributions were not included, meaning the actual totals may be higher. Experts stress the importance of specialist supervision and long-term monitoring for children taking these medications. Specialists highlight that children need support regarding their diet, growth, and overall wellbeing, alongside regular monitoring of side effects and development, as weight often returns when the drugs are stopped.